Discovery of a fluorescent cyclin-dependant kinase inhibitor with potent antiproliferative activity in human breast cancer cells

被引：0
|
作者：
Yenugonda, Venkata Mahidhar
Deb, Tushar B.
Grindrod, Scott C.
Dakshanamurthy, Sivanesan
Yang, Yonghong
Paige, Mikell
Brown, Milton L.
机构：
[1] Georgetown Univ, Med Ctr, Drug Discovery Program, Washington, DC 20007 USA
[2] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
509-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Discovery and Characterization of a Potent and Selective Inhibitor for Human Phosphoinositide-3-kinase γ
    Meleza, Cesar
    Chen, Ada
    Fournier, Jeremy
    Mailyan, Artur
    Mata, Guillaume
    Jeffrey, Jenna
    Banuelos, Jesus
    Zhao, Xiaoning
    Leleti, Manmohan
    Jin, Lixia
    Powers, Jay
    Matthew, J.
    Young, Stephen
    FASEB JOURNAL, 2020, 34
  • [22] Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity
    Yamasaki, Fumiyuki
    Zhang, Dongwei
    Bartholomeusz, Chandra
    Sudo, Tamotsu
    Hortobagyi, Gabriel N.
    Kurisu, Kaoru
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) : 2168 - 2177
  • [23] Abemaciclib, a potent cyclin-dependent kinase 4 and 6 inhibitor, for treatment of ER-positive metastatic breast cancer
    Lee, Karla A.
    Shepherd, Scott T. C.
    Johnston, Stephen R. D.
    FUTURE ONCOLOGY, 2019, 15 (29) : 3309 - 3326
  • [24] Porphyrin conjugates of Ibuprofen and their antiproliferative activity against human prostate and breast cancer cells
    Padilla-Monroy, Salma
    Martinez-Klimova, Elena
    Ramirez-Apan, Teresa
    Nieto-Camacho, Antonio
    Calderon-Pardo, Jose
    Martinez-Garcia, Marcos
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2018, 8 (01): : 3039 - 3047
  • [25] The anticancer of thioflavanone in human breast cancer cells via antiproliferative activity and apoptosis induction
    Kim, Gun-Hee
    Choi, Eun Jeong
    Lee, Jae In
    FASEB JOURNAL, 2011, 25
  • [26] Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells
    Motwani, M
    Li, XK
    Schwartz, GK
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 924 - 932
  • [27] Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy
    Tan, AR
    Swain, SM
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 77 - 85
  • [28] Discovery of a synthetic taiwaniaquinoid with potent in vitro and in vivo antitumor activity against breast cancer cells
    Mut-Salud, Nuria
    Guardia, Juan J.
    Fernandez, Antonio
    Blancas, Isabel
    Zentar, Houda
    Garrido, Jose M.
    Alvarez-Manzaneda, Enrique
    Chahboun, Rachid
    Rodriguez-Serrano, Fernando
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [29] Discovery and Preclinical Development of IIIM-290, an Orally Active Potent Cyclin-Dependent Kinase Inhibitor
    Bharate, Sandip B.
    Kumar, Vikas
    Jain, Shreyans K.
    Mintoo, Mubashir J.
    Guru, Santosh K.
    Nuthakki, Vijay K.
    Sharma, Mohit
    Bharate, Sonali S.
    Gandhi, Sumit G.
    Mondhe, Dilip M.
    Bhushan, Shashi
    Vishwakarma, Ram A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1664 - 1687
  • [30] Discovery of Autophagy Inhibitors with Antiproliferative Activity in Lung and Pancreatic Cancer Cells
    Nordstrom, Lars Ulrik
    Sironi, Juan
    Aranda, Evelyn
    Maisonet, Jorge
    Perez-Soler, Roman
    Wu, Peng
    Schwartz, Edward L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (02): : 134 - 139
12345